CytomX Therapeutics CTMX
NASDAQ CTMX
$2.72 -0.03 (-0.91%)
As of: Sep 30, 2026 · 10:04 AM EDT

CytomX Therapeutics (CTMX) Total Non-Current Liabilities (2014 - 2026)

Updated

CytomX Therapeutics (CTMX) reported Total Non-Current Liabilities of $74.69 million for Q2 2026, up 46.7% from $50.91 million a year earlier and up 113.4% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, CytomX Therapeutics posted Total Non-Current Liabilities of $48.21 million, down 58.8% from FY2024.

  • Total Non-Current Liabilities has declined for three consecutive years, with a three-year compound annual growth rate of -48.2% (FY2022 to FY2025).
  • By year, Total Non-Current Liabilities came in at $116.87 million in FY2024 (-52.4%), $245.35 million in FY2023 (-29.2%) and $346.64 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Total Non-Current Liabilities since Q4 2024.
  • Year over year, Total Non-Current Liabilities gained in 1 of the last eight quarters, with an average decline of 45.7%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2026 (growth of 46.7%); the low point was Q2 2025 (a decline of 72.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $35 million (Q1 2026), $48.21 million (Q4 2025) and $46.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 CytomX Therapeutics 586.15 Mn -371.52 Mn - 74.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74.69 Mn
Mar 31, 2026 35.00 Mn
Dec 31, 2025 48.21 Mn
Sep 30, 2025 46.57 Mn
Jun 30, 2025 50.91 Mn
Mar 31, 2025 69.27 Mn
Dec 31, 2024 116.87 Mn
Sep 30, 2024 158.38 Mn
Jun 30, 2024 186.45 Mn
Mar 31, 2024 212.43 Mn
Dec 31, 2023 245.35 Mn
Sep 30, 2023 269.65 Mn
Jun 30, 2023 294.00 Mn
Dec 31, 2022 346.64 Mn
Jun 30, 2022 314.62 Mn
Dec 31, 2019 314.96 Mn
Sep 30, 2019 289.47 Mn
Jun 30, 2019 302.82 Mn
Mar 31, 2019 320.98 Mn
Dec 31, 2018 318.23 Mn
API Access

CytomX Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CTMX&period=max&api_key=YOUR_API_KEY